Author pages are created from data sourced from our academic publisher partnerships and public sources.
Diagnosis, management, and treatment of hepatitis C: An update
This document has been approved by the AASLD, the Infectious Diseases Society of America, and the American College of Gastroenterology.
An Update on Treatment of Genotype 1 Chronic Hepatitis C Virus Infection: 2011 Practice Guideline by the American Association for the Study of Liver Diseases
The standard of care (SOC) therapy for patients with chronic hepatitis C virus (HCV) infection has been the use of both peginterferon (PegIFN) and ribavirin (RBV). These drugs are administered for… Expand
Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study.
BACKGROUND/AIMS It is unclear whether tumor location, size, or the presence of multiple endocrine neoplasia type 1 (MEN-1) alters metastatic rate and survival in patients with pancreatic endocrine… Expand
National Institutes of Health consensus development conference statement: Management of hepatitis B
Hepatitis B is a major cause of liver disease worldwide, ranking as a substantial cause of cirrhosis and hepatocellular carcinoma. The development and use of a vaccine for hepatitis B virus (HBV) has… Expand
Prospective Multicenter Study of Eligibility for Antiviral Therapy Among 4,084 U.S. Veterans with Chronic Hepatitis C Virus Infection
- E. Bini, N. Bräu, +24 authors T. Wright
- The American Journal of Gastroenterology
- 1 August 2005
BACKGROUND:Many veterans may not be candidates for hepatitis C virus (HCV) treatment due to contraindications to therapy. The aims of this study were to determine the proportion of HCV-infected… Expand
Use of complementary and alternative medicine in patients with liver disease
- D. Strader, B. Bacon, +7 authors L. Seeff
- American Journal of Gastroenterology
- 1 September 2002
OBJECTIVES:Complementary and alternative medicine (CAM) is used by 42% of the U.S. population. Its use among patients with chronic liver disease has not been well defined. Toward that end, we… Expand
Low-positive anti-hepatitis C virus enzyme immunoassay results: an important predictor of low likelihood of hepatitis C infection.
- D. R. Dufour, Mageli Talastas, Maria D A Fernandez, B. Harris, D. Strader, L. Seeff
- Clinical chemistry
- 1 March 2003
BACKGROUND Tests for hepatitis C antibodies (anti-HCV enzyme immunoassays) are usually described as positive or negative. Several studies, mainly in blood donors, have found that specimens with low… Expand
Zollinger-Ellison syndrome can be the initial endocrine manifestation in patients with multiple endocrine neoplasia-type I.
PURPOSE To determine whether patients with multiple endocrine neoplasia type I (MEN-I) can initially present with Zollinger-Ellison syndrome (ZES), and to learn whether ZES exhibits any… Expand
Light, but not heavy alcohol drinking, stimulates paraoxonase by upregulating liver mRNA in rats and humans.
- M. Rao, P. Marmillot, +4 authors M. Lakshman
- Chemistry, Medicine
- Metabolism: clinical and experimental
- 1 October 2003
Paraoxonase 1 (PON) may contribute to the cardioprotective action of high-density lipoprotein (HDL) because it inhibits low-density lipoprotein (LDL) oxidation, a prerequisite for the onset of… Expand
The natural history of chronic hepatitis C infection.
Hepatitis C is among the most common causes of chronic liver disease affecting approximately 1% of the world's population. End-stage hepatitis C virus (HCV)-related chronic liver disease is the… Expand